US Broker Ratings

Dyne Therapeutics, Inc. (DYN) Stock Analysis: Unveiling a 117% Potential Upside in Biotechnology

Dyne Therapeutics, Inc. (NASDAQ: DYN) is catching the attention of investors, particularly those with a keen eye on the biotechnology sector. With a robust market capitalization..

LifeStance Health Group, Inc. (LFST) Investor Outlook: Analyzing a 21.6% Potential Upside with Strong Buy Ratings

LifeStance Health Group, Inc. (NASDAQ: LFST) is making waves in the healthcare sector, particularly within the medical care facilities industry. Headquartered in Scottsdale, Arizona, LifeStance provides..

Mesoblast Limited (MESO) Stock Analysis: Exploring an 87% Upside Potential for Investors

Mesoblast Limited (MESO), a biotechnology company based in Australia, is carving a niche in the healthcare sector with its innovative regenerative medicine products. With a market..

Surgery Partners, Inc. (SGRY) Stock Analysis: Healthcare Growth with a 57% Potential Upside

Surgery Partners, Inc. (NASDAQ: SGRY) is a prominent player in the healthcare sector, specifically within the medical care facilities industry. With a robust market capitalization of..

Galapagos NV (GLPG) Stock Analysis: Navigating the Upside Amidst Biotech Volatility

Galapagos NV (GLPG), a pioneering biotech company headquartered in Mechelen, Belgium, is capturing the attention of the healthcare investment community with its innovative approach to developing..

Novavax, Inc. (NVAX) Stock Analysis: Exploring a 33.84% Potential Upside in the Biotechnology Sector

Investors are keeping a watchful eye on Novavax, Inc. (NVAX), a notable player in the biotechnology sector with a market capitalization of $1.56 billion. The company’s..

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Exploring a 24.76% Potential Upside

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a biopharmaceutical firm specializing in treatments for central nervous system (CNS) diseases, has captured investor attention with its promising market position..

Omnicell, Inc. (OMCL) Stock Analysis: Unpacking a 9.3% Potential Upside in Healthcare Innovation

Omnicell, Inc. (NASDAQ: OMCL) is a key player in the healthcare sector, particularly in the niche of health information services. Known for its advanced medication management..

Disc Medicine, Inc. (IRON) Stock Analysis: Biotech Innovator with a 57% Upside Potential

Disc Medicine, Inc. (NASDAQ: IRON), a pioneering entity in the biotechnology sector, is drawing significant attention from investors due to its promising portfolio and strong analyst..

GRAIL, Inc. (GRAL) Stock Analysis: Navigating a 26.3% Revenue Growth in the Healthcare Sector

Investors with an eye on the healthcare sector might find GRAIL, Inc. (NASDAQ: GRAL) a compelling story, thanks to its significant 26.3% revenue growth and innovative..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: Navigating Growth with a 6.12% Potential Upside

For investors exploring opportunities within the healthcare sector, Amneal Pharmaceuticals, Inc. (NYSE: AMRX) presents an intriguing prospect. With a market capitalization of $4.27 billion, Amneal operates..

Neogen Corporation (NEOG) Stock Analysis: A Diagnostic Innovator with 16.55% Potential Upside

Neogen Corporation (NEOG), a key player in the healthcare sector focusing on diagnostics and research, has garnered attention from investors due to its notable potential upside..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Unveiling a 44.95% Potential Upside for Investors

Pacira BioSciences, Inc. (NASDAQ: PCRX) stands at an intriguing junction for investors with its robust portfolio in non-opioid pain management solutions. Specializing in the healthcare sector,..

Schrodinger, Inc. (SDGR) Investor Outlook: Unveiling a 60.98% Potential Upside with Strong Buy Ratings

Schrodinger, Inc. (NASDAQ: SDGR) stands as a compelling player in the healthcare sector, specifically within the health information services industry. With its market capitalization hovering around..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: 167% Potential Upside Sparks Investor Interest

Investors with a keen eye on the biotechnology sector should consider ARS Pharmaceuticals, Inc. (NASDAQ: SPRY), a promising player in the healthcare industry. With its headquarters..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: A Promising Biotech Play with 20.63% Potential Upside

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) is a burgeoning player in the biotechnology space, focusing on innovative treatments for dermatological diseases. Headquartered in Westlake Village, California, Arcutis..

Premier, Inc. (PINC) Stock Analysis: Navigating Healthcare with a 2.97% Dividend Yield

Premier, Inc. (NASDAQ: PINC) stands as a notable entity within the healthcare sector, particularly in the realm of Health Information Services. With a market capitalization of..

Apogee Therapeutics, Inc. (APGE) Stock Analysis: Unveiling a 49.24% Upside in Biotech

Apogee Therapeutics, Inc. (NASDAQ: APGE), a burgeoning name in the biotechnology sector, is attracting significant investor attention with its promising clinical-stage developments and substantial upside potential...

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Evaluating a 27.3% Potential Upside in Healthcare Innovation

Tandem Diabetes Care, Inc. (TNDM) stands at the forefront of medical device innovation, specializing in cutting-edge technology solutions for diabetes management. With a market capitalization of..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: Exploring a 29% Potential Upside in Biotech Innovation

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a noteworthy player in the biotechnology sector, has been turning investors’ heads with a market capitalization of $2.88 billion and a..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds